A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis

Clinical trial NCT02020889 · COMPLETED

Trial details

NCT number: NCT02020889
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Churg-Strauss Syndrome

Start date: 2014-02-05
Primary completion: 2016-09-05
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.